Skip to main content
. 2018 Apr 13;13:1187–1194. doi: 10.2147/COPD.S159246

Figure 2.

Figure 2

Patient disposition.

Notes: aThree patients withdrew following treatment with placebo MDI and two withdrew following treatment with GP MDI 14.4 μg. bConsidered by the investigator or designee.

Abbreviations: GP, glycopyrronium; MDI, metered dose inhaler.